Nirmatrelvir is a peptidomimetic antiviral medication that functions as a 3C-like (3CL) protease inhibitor, indicated for the treatment of mild-to-moderate COVID-19 in patients at high risk for progression… Read more
![Chemical structure of (1R,2S,5S)-3-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S5S-3-R-33-Dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-3-((S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F394735-37-6-1R2S5S-3-S-2-tert-Butoxycarbonylamino-33-dimethylbutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-3-((S)-2-Amino-3,3-dimethylbutanoyl)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2883654-28-0-1R2S5S-3-S-2-Amino-33-dimethylbutanoyl-N-S-1-cyano-2-S-2-oxopyrrolidin-3-ylethyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-3-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2755812-45-2-1R2S5S-3-S-33-Dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carbonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1037559-82-2-1R2S5S-66-Dimethyl-3-azabicyclo3.1.0hexane-2-carbonitrile.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((R)-1-Cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S5S-N-R-1-Cyano-2-R-2-oxopyrrolidin-3-ylethyl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((R)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2755812-41-8-1R2S5S-N-R-1-Cyano-2-S-2-oxopyrrolidin-3-ylethyl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-c.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((S)-1-Amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2755812-81-6-1R2S5S-N-S-1-Amino-1-oxo-3-S-2-oxopyrrolidin-3-ylpropan-2-yl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((S)-1-Cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S5S-N-S-1-Cyano-2-R-2-oxopyrrolidin-3-ylethyl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((R)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S5S-N-S-1-Cyano-2-S-2-oxopyrrolidin-3-ylethyl-3-R-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-N-(2,2,2-trifluoroacetyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S5S-N-S-1-Cyano-2-S-2-oxopyrrolidin-3-ylethyl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-N-222-trifluoroacetyl-3-azabicyclo3.1.0h.png&w=3840&q=75)
![Chemical structure of (1S,2R,5R)-N-((R)-1-Cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-((R)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S2R5R-N-R-1-Cyano-2-R-2-oxopyrrolidin-3-ylethyl-3-R-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1S,2R,5R)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((R)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S2R5R-N-S-1-Cyano-2-S-2-oxopyrrolidin-3-ylethyl-3-R-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)
![Chemical structure of (1S,2R,5R)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S2R5R-N-S-1-Cyano-2-S-2-oxopyrrolidin-3-ylethyl-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamide.png&w=3840&q=75)


![Chemical structure of (aS,3S)-a-[(tert-Butyloxycarbonyl)amino]-2-oxo-3-pyrrolidinepropanoic Acid Methyl Ester (BSC)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F328086-60-8-aS3S-a-tert-Butyloxycarbonylamino-2-oxo-3-pyrrolidinepropanoic-Acid-Methyl-Ester-BSC.png&w=3840&q=75)



![Chemical structure of (S)-2-((1R,2S,5S)-3-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamido)-3-((S)-2-oxopyrrolidin-3-yl)propanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3057189-15-5-S-2-1R2S5S-3-S-33-Dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamido-3-S-2-oxopyrrolidin-3-ylpro.png&w=3840&q=75)






![Chemical structure of Isopropyl (S)-2-((1R,2S,5S)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamido)-3-((S)-2-oxopyrrolidin-3-yl)propanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FIsopropyl-S-2-1R2S5S-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamido-3-S-2-oxopyrrolidin-3-ylpropan.png&w=3840&q=75)
![Chemical structure of Methyl (1R,2R,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1932411-98-7-Methyl-1R2R5S-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F565456-77-1-Methyl-1R2S5S-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxylate-Hydrochloride.png&w=3840&q=75)


![Chemical structure of Methyl (S)-2-((1R,2S,5S)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamido)-3-((S)-2-oxopyrrolidin-3-yl)propanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2879641-46-8-Methyl-S-2-1R2S5S-3-S-33-dimethyl-2-222-trifluoroacetamidobutanoyl-66-dimethyl-3-azabicyclo3.1.0hexane-2-carboxamido-3-S-2-oxopyrrolidin-.png&w=3840&q=75)


![Chemical structure of N-((S)-1-((1R,2S,5S)-2-Cyano-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl)-3,3-dimethyl-1-oxobutan-2-yl)-2,2,2-trifluoroacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2801608-29-5-N-S-1-1R2S5S-2-Cyano-66-dimethyl-3-azabicyclo3.1.0hexan-3-yl-33-dimethyl-1-oxobutan-2-yl-222-trifluoroacetamide.png&w=3840&q=75)






Nirmatrelvir is a peptidomimetic antiviral medication that functions as a 3C-like (3CL) protease inhibitor, indicated for the treatment of mild-to-moderate COVID-19 in patients at high risk for progression to severe disease, typically when co-administered with ritonavir to maintain therapeutic plasma concentrations. This category provides a comprehensive selection of Nirmatrelvir reference standards, including pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, degradation studies, and method validation to ensure regulatory compliance and product quality. By utilizing these well-characterized standards, researchers can accurately identify, quantify, and control potential process-related impurities and degradation products throughout the drug development lifecycle. These high-purity compounds support rigorous analytical testing and quality control protocols required to verify the identity, strength, and safety of pharmaceutical substances in alignment with global guidelines.